Join the Royal Society of Medicine Endocrinology and Diabetes Section for this obesity pharmacotherapy masterclass, a dedicated full-day event exploring the latest advances in the medical management of obesity and the rapidly evolving role of GLP-1-based treatments. Bringing together leading experts in obesity, endocrinology and cardiometabolic medicine, the programme combines the latest science with practical discussion to support evidence-based obesity care.
Obesity pharmacotherapy is transforming clinical practice, yet the pace of development means many healthcare professionals face challenges keeping up with emerging evidence and translating clinical trial findings into day-to-day care. This masterclass addresses that gap through expert-led sessions covering the science underpinning obesity treatments, efficacy and safety evidence, broader health outcomes, future therapies, and practical implementation within multidisciplinary clinical services.
This full-day masterclass is structured to bridge science and practice, with the morning session dedicated to the latest evidence in obesity pharmacotherapy and the afternoon focused on practical implementation in clinical care. Delegates will hear from experts on the evolving science of obesity, current and future treatments, and broader health outcomes, before moving into an interactive session exploring patient pathways, multidisciplinary support, service delivery and real-world clinical challenges. Dedicated breaks throughout the day will provide opportunities for discussion and networking with colleagues and speakers.
Why attend?
- Hear from leading experts, including Professor Carel le Roux, Professor Naveed Sattar, Dr Susan Connolly and Dr Mick Crotty
- Gain an up-to-date overview of GLP-1-based treatments and the latest evidence in obesity pharmacotherapy
- Explore how obesity treatments affect cardiovascular, mental, functional and metabolic outcomes beyond weight loss
- Take part in the interactive afternoon session, putting challenging clinical questions directly to experts while exploring patient selection, treatment pathways and multidisciplinary obesity care, with practical insights drawn from clinical experience
Aims of the event
- Provide an update on the latest scientific understanding of obesity and advances in obesity pharmacotherapy
- Explore current and emerging evidence on the efficacy, safety and wider health impacts of obesity treatments
- Support participants to apply evidence-based approaches to obesity management and service development
Learning outcomes
- Explain the latest scientific understanding of obesity and its implications for treatment
- Critically appraise current evidence on obesity pharmacotherapy, including GLP-1-based treatments
- Evaluate the impact of obesity pharmacotherapy on physical, mental and functional health outcomes
- Identify future developments and emerging therapies in obesity management
- Apply evidence-based approaches to service delivery, multidisciplinary working and obesity care pathways in clinical practice
Who should attend?
- Consultants, GPs and SAS doctors
- Endocrinologists and diabetes specialists
- Nurses and allied health professionals involved in obesity care
- Dietitians and nutrition professionals
- Psychologists and behavioural specialists
- Physical activity specialists and multidisciplinary obesity teams
If you are booking a non-member ticket, lunch is included at no extra cost - simply opt in when booking. Lunch is not included with member tickets and must be purchased separately by selecting the lunch option when booking.
Attend educational events for free
RSM members enjoy free access to over 200 expert-led events each year, including CPD-accredited learning.
Become a member
From under £10 p/mo
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube